Zobrazeno 1 - 10
of 205
pro vyhledávání: '"T Skovsgaard"'
Publikováno v:
Acta Pathologica Microbiologica Scandinavica Series A :Pathology. :325-332
Clonal interaction among two subpopulations of Ehrlich ascites carcinoma was studied during in vivo growth in immune competent N/D mice in which the cell lines had been propagated for several years as ascites tumors. A growth inhibitory interaction b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::732eaa23132c65e060117b1bde2d3ce9
https://doi.org/10.1111/j.1699-0463.1987.tb00048_95a.x
https://doi.org/10.1111/j.1699-0463.1987.tb00048_95a.x
Publikováno v:
European Journal of Haematology. 42:59-67
Multidrug resistance involves cross-resistance between some of the most important agents in cancer chemotherapy, including the anthracyclines and the vinca alkaloids. It is closely related to an active extrusion of the drugs from the resistant cells,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aca7ece68f21d57dea8300f4e3c479c7
https://doi.org/10.1111/j.1600-0609.1989.tb01239.x
https://doi.org/10.1111/j.1600-0609.1989.tb01239.x
Autor:
F. Lofts, K J Hamberg, J Bach Hansen, J Dancey, Thomas J. Evans, T Skovsgaard, F Burcharth, William P. Steward, T Skov, S Erlinger, Kim Dalhoff, L Astrup, O Rosmorduc
Publikováno v:
British Journal of Cancer
Hepatocellular carcinoma (HCC) is a common malignant tumour, which has a poor prognosis. Surgical resection can be curative but most patients are inoperable and most chemotherapy agents have minimal activity in this disease. Seocalcitol, a vitamin D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00e31abdac849c8c1460b2bb121912bc
https://doi.org/10.1038/sj.bjc.6601104
https://doi.org/10.1038/sj.bjc.6601104
Autor:
T. Skovsgaard, H. Hegner
Publikováno v:
2008 Annual IEEE Student Paper Conference.
The goal of this research is to estimate the maximum amount of noise of a pointing device that still makes interaction with a Windows interface possible. This work proposes zoom as an alternative activation method to the more well-known interaction m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b10d1835cfd471e2bcd3f2d66b2064cf
https://doi.org/10.1109/aispc.2008.4460544
https://doi.org/10.1109/aispc.2008.4460544
Autor:
T. Skovsgaard, C.J.A. Punt, L. Hammershaimb, J. Douma, J. Schüller, J. J. Croles, J. Zhang, E. W. Muller, H. Lochs, H.J. Keizer, C. H. H. Ten Napel
Publikováno v:
Annals of Oncology, 13, 81-6
Annals of oncology, 13(1), 81-86. Oxford University Press
Annals of Oncology, 13, 1, pp. 81-6
Annals of oncology, 13(1), 81-86. Oxford University Press
Annals of Oncology, 13, 1, pp. 81-6
Item does not contain fulltext BACKGROUND: Trimetrexate (TMTX) is a biochemical modulator of 5-fluorouracil (5-FU) and leucovorin (LV). Phase II trials have shown promising activity of 5-FU/LV/TMTX in patients with advanced colorectal cancer (ACC). T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4827ac55aa0af8f3033d5953c11d28c7
http://hdl.handle.net/2066/185518
http://hdl.handle.net/2066/185518
Autor:
T. Skovsgaard, Claire Barton, N. G. P. Davidson, D.T. Cirkel, D. J. Richel, Martine Piccart, S. Knight, J. Bonneterre
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 12(9)
SummaryBackground Eniluracil is an effective inactivator of dihydro-pyrimidine dehydrogenase, the initial and rate limiting enzymein the catabohsm of fluorouracil The current study was doneto determine the objective tumour response of a 28-day oralre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a705a553f7eeb954a32f33bcd8b0494
https://pubmed.ncbi.nlm.nih.gov/11697836
https://pubmed.ncbi.nlm.nih.gov/11697836
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 12(1)
Summary Background Analysis of prognostic factors in patients with metastatic breast cancer treated with epirubicin-based chemotherapy Patients and methods Data from 469 patients treated with epirubicin-based chemotherapy for metastatic breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37b7432c037d49d3b0ae4a14a68d5425
https://pubmed.ncbi.nlm.nih.gov/11249054
https://pubmed.ncbi.nlm.nih.gov/11249054
Autor:
T. Skovsgaard Jensen, D. Oulid-Aïssa, T. Linné, Mogens Kjaer, S. Pyrhnen, Bengt Glimelius, B. Boussard, T. Tveit, R. Ristamaki, Per Pfeiffer
Publikováno v:
European Journal of Cancer. 37:S305-S306
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c7b6de96780df2c71bdcd8691089beb
https://doi.org/10.1016/s0959-8049(01)81620-8
https://doi.org/10.1016/s0959-8049(01)81620-8
Autor:
J.J. Schulz, J.V. Cox, G. Koch, W. Oster, C.J.A. Punt, Charles D. Blanke, T. Skovsgaard, H.J. Keizer, Daniel G. Haller, J. Schueller
Publikováno v:
European Journal of Cancer. 37:S291-S292
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::243c08eaafedfb4f51c6584fce28a325
https://doi.org/10.1016/s0959-8049(01)81567-7
https://doi.org/10.1016/s0959-8049(01)81567-7
Autor:
T. Skovsgaard, P. Liati, S. B. Kaye, R. Sorio, F. Calabresi, Cristiana Sessa, Franco Cavalli, Thomas Cerny
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 2(10)
Summary The new anthracycline analogue, 4’-iodo-4’-deoxydoxorubicin (I-DOX), was administered at 70 mg/m2 as first chemotherapy in 61 patients with advanced NSCL (19), colon (20) and breast cancers (22). Treatment was repeated every 3 weeks; the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65a96cf40b073d3b7796e4f43ef4b0b9
https://pubmed.ncbi.nlm.nih.gov/1666296
https://pubmed.ncbi.nlm.nih.gov/1666296